Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin

British Journal of Dermatology

Volumn 160, Issue 2, 2009, Pages 319-324

  Johansen, C ^a   Usher, P A ^b   Kjellerup, R B ^a   Lundsgaard, D ^b   Iversen, L ^a   Kragballe, K ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Interleukin 17; Interleukin 17 receptors; Psoriasis

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17B; INTERLEUKIN 17C; INTERLEUKIN 17F; INTERLEUKIN 27; INTERLEUKIN RECEPTOR; ISOPROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PSORIASIS; PUNCH BIOPSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELLS, CULTURED; GENE EXPRESSION; HUMANS; INTERLEUKIN-17; PROTEIN ISOFORMS; PSORIASIS; RECEPTORS, INTERLEUKIN-17; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 58349105187     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08902.x     Document Type: Article

References (41)

1. Aggarwal S, Ghilardi N, Xie MH et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003 278 : 1910 14.
2. Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005 6 : 1123 32.
3. Liang SC, Tan XY, Luxenberg DP et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006 203 : 2271 9.
4. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007 8 : 345 50.
5. Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007 8 : 950 7.
6. Chen Z, Tato CM, Muul L et al. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 2007 56 : 2936 46.
7. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441 : 235 8.
8. Mangan PR, Harrington LE, O'Quinn DB et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006 441 : 231 4.
9. Veldhoen M, Hocking RJ, Atkins CJ et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006 24 : 179 89.
10. Schmidt-Weber CB, Akdis M, Akdis CA. TH17 cells in the big picture of immunology. J Allergy Clin Immunol 2007 120 : 247 54.
11. Stern RS. Psoriasis. Lancet 1997 350 : 349 53.
12. Nickoloff BJ, Qin JZ, Nestle FO. Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol 2007 33 : 45 56.
13. Blauvelt A. T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis. J Invest Dermatol 2008 128 : 1064 7.
14. Fitch E, Harper E, Skorcheva I et al. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 2007 9 : 461 7.
15. Nickoloff BJ. Cracking the cytokine code in psoriasis. Nat Med 2007 13 : 242 4.
16. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008 128 : 1207 11.
17. Moseley TA, Haudenschild DR, Rose L et al. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003 14 : 155 74.
18. Starnes T, Robertson MJ, Sledge G et al. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 2001 167 : 4137 40.
19. Yao Z, Fanslow WC, Seldin MF et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995 3 : 811 21.
20. Yao Z, Painter SL, Fanslow WC et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995 155 : 5483 6.
21. Weaver CT, Hatton RD, Mangan PR et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007 25 : 821 52.
22. Starnes T, Broxmeyer HE, Robertson MJ et al. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 2002 169 : 642 6.
23. Li H, Chen J, Huang A et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci U S A 2000 97 : 773 8.
24. Angkasekwinai P, Park H, Wang YH et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007 204 : 1509 17.
25. Sharkhuu T, Matthaei KI, Forbes E et al. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin Exp Allergy 2006 36 : 1575 83.
26. Wang YH, Angkasekwinai P, Lu N et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007 204 : 1837 47.
27. Hymowitz SG, Filvaroff EH, Yin JP et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 2001 20 : 5332 41.
28. Gaffen SL, Kramer JM, Yu JJ et al. The IL-17 cytokine family. Vitam Horm 2006 74 : 255 82.
29. Zaba LC, Cardinale I, Gilleaudeau P et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 2007 204 : 3183 94.
30. Arican O, Aral M, Sasmaz S et al. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005 2005 : 273 9.
31. Johansen C, Funding AT, Otkjaer K et al. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J Immunol 2006 176 : 1431 8.
32. Johansen C, Moeller K, Kragballe K et al. The activity of caspase-1 is increased in lesional psoriatic epidermis. J Invest Dermatol 2007 127 : 2857 64.
33. Shen F, Gaffen SL. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 2008 41 : 92 104.
34. Hwang SY, Kim HY. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells 2005 19 : 180 4.
35. Komiyama Y, Nakae S, Matsuki T et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006 177 : 566 73.
36. Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005 201 : 233 40.
37. Lee E, Trepicchio WL, Oestreicher JL et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004 199 : 125 30.
38. Haider AS, Lowes MA, Suarez-Farinas M et al. Identification of cellular pathways of 'type 1', Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol 2008 180 : 1913 20.
39. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007 445 : 866 73.
40. Hurst SD, Muchamuel T, Gorman DM et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002 169 : 443 53.
41. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004 21 : 467 76.